Neurologists could consider a higher threshold for offering steroid treatment to patients with MS experiencing an acute relapse during the COVID-19 pandemic. The practice tip was included in advice from an international group of MS experts, including Professor Simon Broadley from the Menzies Health Institute Queensland and Griffith University. The article, published in Neurology, said ...
Tips on treating MS and NMOSD during pandemic outlined
By Mardi Chapman
7 Apr 2020